Elbit Medical Technologies Ltd
Tel Aviv Stock ExchangeTotal Valuation
Elbit Medical Technologies Ltd carries a market capitalization of 20.14M, placing it among publicly traded companies globally. Its enterprise value stands at 75.68M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 20.14M |
| Enterprise Value | 75.68M |
Share Statistics
Elbit Medical Technologies Ltd currently has 92.79M shares outstanding.
| Shares Outstanding | 92.79M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Elbit Medical Technologies Ltd trades at a trailing price-to-earnings ratio of 48.73.
| PE Ratio | 48.73 |
| PS Ratio | N/A |
| PB Ratio | -1.17 |
| P/TBV Ratio | 1.22 |
| P/FCF Ratio | -75.77 |
| P/OCF Ratio | -75.77 |
Enterprise Valuation
| EV / Sales | N/A |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 31.31 |
Financial Position
Elbit Medical Technologies Ltd maintains a current ratio of 1.21, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 78.63, indicating elevated leverage, while an interest coverage ratio of -0.16 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.21 |
| Quick Ratio | 0.08 |
| Debt / Equity | 78.63 |
| Debt / EBITDA | -64.40 |
| Interest Coverage | -0.16 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 1.25 |
| Return on Invested Capital (ROIC) | -0.65 |
| Return on Capital Employed (ROCE) | -40.87 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Elbit Medical Technologies Ltd's stock has declined approximately -3.8961% over the past 52 weeks. The 50-day moving average sits at 23.69, while the 200-day moving average is 22.16.
| Beta (5Y) | N/A |
| 52-Week Price Change | -3.8961% |
| 50-Day Moving Average | 23.69 |
| 200-Day Moving Average | 22.16 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -477,000.00, while operating income came in at -477,000.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -477,000.00 |
| Pretax Income | 978,000.00 |
| Net Income | 978,000.00 |
| EBITDA | -477,000.00 |
| EBIT | -477,000.00 |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
Elbit Medical Technologies Ltd holds 2.70M in cash and equivalents against 30.72M in total debt, resulting in a net debt position of 28.02M. Total book value stands at -40.88M, with working capital of 6.97M providing operational flexibility.
| Cash & Cash Equivalents | 2.70M |
| Total Debt | 30.72M |
| Net Debt | 28.02M |
| Equity (Book Value) | -40.88M |
| Book Value Per Share | -0.42 |
| Working Capital | 6.97M |
Cash Flow
Elbit Medical Technologies Ltd produced -629,000.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -629,000.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -629,000.00 |
| FCF Per Share | -0.01 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 32.03 |
| FCF Yield | -1.32 |
Stock Splits
Elbit Medical Technologies Ltd's most recent stock split took place on February 8, 2018 with a 8:1 split ratio.
| Last Split Date | 2/8/2018 |
| Split Ratio | 8:1 |
Scores
Elbit Medical Technologies Ltd posts an Altman Z-Score of 0.09, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 0.09 |